Table 2.
Role of GA in tissue biomarker changes.
| Groups | NBT reduction (pM / Min / mg of tissue) | MPO (unit / Min /mg of protein) |
|---|---|---|
| Control | 3.53 ± 1.73 | 14.81 ± 1.91 |
| GA per se | 3.27 ± 1.21 | 15.49 ± 1.17 |
| PT | 28.81 ± 0.78* | 95.39 ± 1.94* |
| PT + GA (20) | 9.91 ± 1.52# | 43.79 ± 2.82# |
| PT + GA (40) | 5.04 ± 1.17# | 37.94 ± 2.61# |
| PT + PreG (5) | 4.62 ± 0.71# | 19.79 ± 1.85# |
Digits in parenthesis indicate dose in mg/kg. Data were expressed as mean ± SD, n = 6 mice per group. *p < 0.05 vs control group. #p < 0.05 vs PT control group. Abbreviation: GA, gallic acid, PT, paclitaxel; PreG, pregabalin; NBT, nitroblue tetrazolium; and MPO, myeloperoxidase.